Bortezomib Intermediate II

Bortezomib Intermediate II

205393-21-1

C₂₄H₃₇BN₂O₃.ClH

MFCD18252917

bortezomib intermediate ii ; (alphas)-alpha-amino-n-[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide hydrochloride ; benzenepropanamide, a-amino-n-[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-,hydrochloride (1:1), (as)- ; bortezomib intermediates i ; benzenepropanamide, a-amino-n-[1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)-3-methylbutyl]-,monohydrochloride, [3as-[2[s*(r*)],3aa,4b,6b,7aa]]- ; (?s)-?-amino-n-[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide monohydrochloride ; bortezomib intermediates n-2 ; bortezomib intermediates ii ; benzenepropanamide, a-amino-n-[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-, hydrochloride (1:1), (as) ; benzenepropanamide,a-amino-n-[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-,monohydrochloride, (as)- (9ci)